Literature DB >> 8439484

Hypoproteinemia in the hemolytic-uremic syndrome of childhood.

V L Serebruany1, M J Christenson, J Pescetti, R H McLean.   

Abstract

A retrospective review of admission serum protein concentration in 18 children with hemolytic-uremic syndrome (HUS) showed significantly decreased serum total protein, albumin and globulin concentrations upon admission compared with 22 matched controls (P < 0.003). One child with atypical disease without diarrhea had normal serum protein concentrations. A strongly positive correlation (P = 0.006) was found between the age of HUS patients with diarrhea and their lowest total protein concentrations. In 10 children who eventually required hemodialysis, there was a significantly negative correlation (r = -0.8316, P = 0.01) between the admission serum albumin and the patients' highest creatinine levels, suggesting that hypoproteinemia may be a risk factor in the development of renal failure. The pathophysiological and clinical significance of hypoproteinemia in HUS needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439484     DOI: 10.1007/bf00861576

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Influence of antidiarrheal and antimicrobial medications on the hemorrhagic colitis associated with hemolytic-uremic syndrome.

Authors:  W L Robson; R B Scott; G H Fick
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

Review 3.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.

Authors:  N Cimolai; J E Carter; B J Morrison; J D Anderson
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

5.  Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  C Loirat; E Sonsino; N Hinglais; J P Jais; P Landais; J Fermanian
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

6.  Intractable diarrhea of infancy due to lymphangiectasis.

Authors:  D Fried; A Gotlieb; L Zaidel
Journal:  Am J Dis Child       Date:  1974-03

Review 7.  The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin.

Authors:  T A Waldmann; R D Wochner; W Strober
Journal:  Am J Med       Date:  1969-02       Impact factor: 4.965

8.  The hemolytic-uremic syndrome: initial clinical presentation mimicking ulcerative colitis.

Authors:  W Berman
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

9.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

10.  [Primary intestinal lymphangiectasis (Waldmann's disease) and recurrent hemolytic uremic syndrome--a pathogenetic connection?].

Authors:  C Kreisel; N Graben; K Pistor; C Feldhoff
Journal:  Med Welt       Date:  1983-06-03
  10 in total
  3 in total

1.  C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Luciana Meni Bataglia; Ismael Toledo; Laura Beaudoin; Caupolican Alvarado
Journal:  Pediatr Nephrol       Date:  2019-09-02       Impact factor: 3.714

2.  Acute dialysis-associated peritonitis in children with D+ hemolytic uremic syndrome.

Authors:  Marta Adragna; Alejandro Balestracci; Laura García Chervo; Silvina Steinbrun; Norma Delgado; Liliana Briones
Journal:  Pediatr Nephrol       Date:  2011-10-29       Impact factor: 3.714

3.  Serum proteins in the haemolytic uraemic syndrome.

Authors:  G Goos; P Declercq; W Proesmans
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.